KLOTHO Therapeutics - Raised Investor
Klotho Therapeutics, Inc., (KTI) is a privately held biotechnology company developing modified recombinant versions of the human protein Klotho that has shown great potential to delay diseases of aging and improve Therapeutics, Inc. - ?
Headquarters:
San Diego, United States
Founded Date:
2016.0
